The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Polymorphism of apolipoprotein E: Genetics of hyperlipoproteinemia type III
Abstract
Apolipoprotein E from human serum shows a genetic polymorphism determined by two autosomal codominant alleles, Apo En and Apo E d. Homozygosity for the gene Apo E d (phenotype Apo E‐D) results in primary dysbetalipoproteinemia, but only some individuals with this phenotype develop gross hyperlipidemia (hyperlipoproteinemia type III). Vertical transmission of dysbetalipoproteinemia represents pseudodominance due to the high frequency of the gene Apo Ed. Dysbetalipoproteinemia is already expressed in childhood. To assess the influence of other genes on the expression of hyperlipidemia in phenotype Apo E‐D, comparative studies were carried out in kindreds of hypercholesterolemic (group A) and normo‐ or hypocholesterolemic probands with dysbetalipoproteinemia (group B). This demonstrated the occurrence of familial (non‐type III) forms of hyperlipidemia in group A but not in group B kindreds. Distribution of lipoprotein pheno‐types in five of the group A kindreds was consistent with the occurrence of familial combined hyperlipidemia. Apo E phenotypes and hyperlipidemia segregated independently. It is concluded that primary dysbetalipoproteinemia is a frequent monogenic variant of lipoprotein metabolism, but not a disease. Coincidence in one individual of genes for this specific dyslipoproteinemia with any of the genes for monogenic or polygenic forms of familial hyperlipidemia results in hyperlipoproteinemia type III. Hence hyperlipoproteinemia type III is caused by at least two non‐allelic genes and is a polygenic disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other
Mann, H. B., & Whitney, D. R. (1947) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177730491 · Cited by 14,320
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,443
The Metabolic Basis of Inherited Disease.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-5-839_2 · Cited by 1,318
Separation of plasma lipoproteins by density-gradient ultracentrifugation
Redgrave, T. G., Roberts, D. C. K., & West, C. E. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90488-1 · Cited by 1,107
Brown, M. S., & Goldstein, J. L. (1976) · Science · doi:10.1126/science.174194 · Cited by 725
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Self-citationUtermann, G., Jaeschke, M., & Menzel, J. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)81125-2 · Cited by 337
Self-citationFAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASE
Nikkilä, E., & Aro, A. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91598-5 · Cited by 292
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
MORGANROTH, J., LEVY, R. I., & FREDRICKSON, D. S. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-2-158 · Cited by 260
Protides of the Biological Fluids
Skinner, L. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.168 · Cited by 255
Research works printed but not linked: 11
- Bilheimer D. W., 1971, Abnormal metabolism of very low density lipoproteins in type 111, Circulation, 44, 11
- Gofman J. W., 1956, The serum lipoprotein transport system in health, metabolic disorder, atherosclerosis and coronary artery disease, Plasma, 2, 413
- Hall M. H., 1974, A mathematical model for apoprotein kinetics in normal and hyperlipidemic patients, Circulation, 114
- Havel R. J., 1969, Advances in Internal Medicine, 117
- Hazzard W. R., 1971, Impaired removal of very low density lipoprotein (VLDL) “remnants” in the pathogenesis of broad‐beta disease (type III hyperlipoproteinemia), Clin. Res., 19, 476
- 10.1111/j.1399-0004.1976.tb01554.x · doi:10.1111/j.1399-0004.1976.tb01554.x
- Lasser N. L., 1972, The occurrence of type III and type II hyperlipoproteinemia in a single kindred, Clin. Res., 20
- Mishkel M. A., 1971, Protides of the Biological Fluids, 283
- Moser H., 1974, Atherosclerosis, 854
- Namboodiri K. K., 1975, Bivariate analyses of cholesterol and triglyceride levels in families in which probands have type lib lipoprotein phenotype, Amer. J. hum. Genet., 27, 454
- Utermann G., 1977, Protides of the Biological Fluids, 285
Cited by
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Smoking and Cardiovascular Disease: Mechanisms of Endothelial Dysfunction and Early Atherogenesis
Messner, B., & Bernhard, D. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.300156 · Cited by 1,139
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein
Beisiegel, U., Weber, W., Ihrke, G., Herz, J., & Stanley, K. K. (1989) · Nature · doi:10.1038/341162a0 · Cited by 681
Apolipoprotein E in animal models of CNS injury and in alzheimer's disease
Poirier, J. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90156-2 · Cited by 639
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis
Wilson, P. W. F., Schaefer, E. J., Larson, M. G., & Ordovas, J. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.10.1250 · Cited by 539
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study
Wilson, P. W. F. (1994) · JAMA · doi:10.1001/jama.1994.03520210050031 · Cited by 468
Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.
Dallongeville, J., Lussier-Cacan, S., & Davignon, J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41611-6 · Cited by 448
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113243 · Cited by 418
Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E., & Utermann, G. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38833-7 · Cited by 405
Self-citationApolipoprotein E polymorphism in health and disease
Utermann, G. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90610-7 · Cited by 389
Self-citationIsolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene.
Das, H. K., McPherson, J., Bruns, G. A., Karathanasis, S. K., & Breslow, J. L. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88963-3 · Cited by 355
Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112645 · Cited by 345
Rall, S. C., Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4696 · Cited by 345
Apolipoprotein E polymorphism and coronary artery disease.
Menzel, H. J., Kladetzky, R. G., & Assmann, G. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.4.310 · Cited by 344
(1981) · PubMed · Cited by 341
Lusis, A. J., Mar, R., & Pajukanta, P. (2004) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.5.061903.175930 · Cited by 338
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase
BRECKENRIDGE, W., LITTLE, J., ALAUPOVIC, P., WANG, C., KUKSIS, A., KAKIS, G., LINDGREN, F., & GARDINER, G. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90136-8 · Cited by 328
Human Apolipoprotein E4 Domain Interaction
Dong, L.-M., & Weisgraber, K. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19053 · Cited by 318
Li, W. H., Tanimura, M., Luo, C. C., Datta, S., & Chan, L. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38532-1 · Cited by 317
Causative and susceptibility genes for Alzheimer’s disease: a review
Rocchi, A., Pellegrini, S., Siciliano, G., & Murri, L. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00067-4 · Cited by 316
Schneider, W. J., Kovanen, P. T., Brown, M. S., Goldstein, J. L., Utermann, G., Weber, W., Havel, R. J., Kotite, L., Kane, J. P., Innerarity, T. L., et al. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110330 · Cited by 310
Self-citationGenotyping and sequence analysis of apolipoprotein E isoforms*1
EMI, M. (1988) · Genomics · doi:10.1016/0888-7543(88)90130-9 · Cited by 301
The use of measured genotype information in the analysis of quantitative phenotypes in man.
BOERWINKLE, E., & SING, C. F. (1987) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1987.tb00874.x · Cited by 277
Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
Mahley, R. W., Palaoğlu, K. E., Atak, Z., Dawson-Pepin, J., Langlois, A. M., Cheung, V, Onat, H., Fulks, P., Mahley, L. L., & Vakar, F. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40067-7 · Cited by 273
A rapid micromethod for apolipoprotein E phenotyping directly in serum
Havekes, L. M., de Knijff, P., Beisiegel, U., Havinga, J., Smit, M., & Klasen, E. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38697-1 · Cited by 265
Apolipoprotein E synthesis in human kidney, adrenal gland, and liver
Blue, M. L., Williams, D. L., Zucker, S., Khan, S. A., & Blum, C. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.283 · Cited by 226
Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment
BREWER, H. B., ZECH, L. A., GREGG, R. E., SCHWARTZ, D., & SCHAEFER, E. J. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-623 · Cited by 226
Utermann, G., Pruin, N., & Steinmetz, A. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02028.x · Cited by 209
Self-citationStudies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2
Breslow, J. L., Zannis, V. I., SanGiacomo, T. R., Third, J. L., Tracy, T., & Glueck, C. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38060-3 · Cited by 174
Identification of disease treatment mechanisms through the multiscale interactome
Ruiz, C., Zitnik, M., & Leskovec, J. (2021) · Nature Communications · doi:10.1038/s41467-021-21770-8 · Cited by 172
Wardell, M. R., Brennan, S. O., Janus, E. D., Fraser, R., & Carrell, R. W. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113096 · Cited by 159
Utermann, G., Steinmetz, A., & Weber, W. (1982) · Human Genetics · doi:10.1007/bf00569216 · Cited by 149
Self-citationRall, S. C., Weisgraber, K. H., Innerarity, T. L., Bersot, T. P., Mahley, R. W., & Blum, C. B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111085 · Cited by 141
ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
Mooijaart, S. P., Berbée, J. F. P., van Heemst, D., Havekes, L. M., de Craen, A. J. M., Slagboom, P. E., Rensen, P. C. N., & Westendorp, R. G. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030176 · Cited by 129
Smit, M., de Knijff, P., Rosseneu, M., Bury, J., Klasen, E., Frants, R., & Havekes, L. (1988) · Human Genetics · doi:10.1007/bf01790099 · Cited by 127
APO E gene and gene-environment effects on plasma lipoprotein-lipid levels
HAGBERG, J. M., WILUND, K. R., & FERRELL, R. E. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.2.101 · Cited by 118
Weisgraber, K. H., Rall, S. C., Innerarity, T. L., Mahley, R. W., Kuusi, T., & Ehnholm, C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111287 · Cited by 111
Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia.
Kane, J. P., Chen, G. C., Hamilton, R. L., Hardman, D. A., Malloy, M. J., & Havel, R. J. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.1.47 · Cited by 106
Havekes, L., de Wit, E., Leuven, J. G., Klasen, E., Utermann, W., Weber, W., & Beisiegel, U. (1986) · Human Genetics · doi:10.1007/bf00291607 · Cited by 99
Yamamura, T., Yamamoto, A., Sumiyoshi, T., Hiramori, K., Nishioeda, Y., & Nambu, S. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111532 · Cited by 91
Genetic variation in human apolipoprotein E
Wardell, M. R., Suckling, P. A., & Janus, E. D. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38055-x · Cited by 89
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78
Frikke-Schmidt, R., Tybjærg-Hansen, A., Steffensen, R., Jensen, G., & Nordestgaard, B. G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00520-9 · Cited by 77
Hazzard, W. R., Warnick, G. R., Utermann, G., & Albers, J. J. (1981) · Metabolism · doi:10.1016/0026-0495(81)90223-7 · Cited by 77
Self-citationMann, W. A., Gregg, R. E., Sprecher, D. L., & Brewer, H. B. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90043-x · Cited by 75
MAHLEY, R. W., INNERARITY, T. L., RALL, S. C., & WEISGRABER, K. H. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb11860.x · Cited by 75
Smit, M., de Knijff, P., van der Kooij-Meijs, E., Groenendijk, C., van den Maagdenberg, A., Gevers Leuven, J., Stalenhoef, A., Stuyt, P., Frants, R., & Havekes, L. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42759-2 · Cited by 74
de Beer, F., Stalenhoef, A. F. H., Hoogerbrugge, N., Kastelein, J. J. P., Gevers Leuven, J. A., van Duijn, C. M., Havekes, L. M., & Smelt, A. H. M. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.102919 · Cited by 74
Stalenhoef, A. F., Malloy, M. J., Kane, J. P., & Havel, R. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112632 · Cited by 70
Genetic Mutations Affecting Human Lipoprotein Metabolism
Zannis, V. I., & Breslow, J. L. (1985) · Advances in Human Genetics 14 · doi:10.1007/978-1-4615-9400-0_3 · Cited by 65
Delayed post-prandial lipid metabolism in subjects with intra-abdominal visceral fat accumulation
Taira, Hikita, Kobayashi, Bujo, Takahashi, Murano, Morisaki, & Saito (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00454.x · Cited by 47
Wardell, M., Rall, S., Schaefer, E., Kane, J., & Weisgraber, K. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42076-0 · Cited by 40
Lipoprotein Glomerulopathy: First Report in a Chinese Male
Zhang, P., Matalon, R., Kaplan, L., Kumar, A., & Gallo, G. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)81066-3 · Cited by 37
Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.
Moriyama, K., Sasaki, J., Matsunaga, A., Arakawa, F., Takada, Y., Araki, K., Kaneko, S., & Arakawa, K. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90257-v · Cited by 37
Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects
Mailly, F., Xu, C., Xhignesse, M., Lussier-Cacan, S., Talmud, P., Davignon, J., Humphries, S., & Nestruck, A. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42048-6 · Cited by 36
Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patient
HAVEKES, L. M., LEUVEN, J. A. G., CORVEN, E. V., WIT, E. D., & EMEIS, J. J. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb00696.x · Cited by 31
FEUSSNER, G., FUNKE, H., WENG, W., ASSMANN, G., LACKNER, K. J., & ZIEGLER, R. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01511.x · Cited by 28
Wardell, M. R., Rall, S., Brennan, S., Nye, E., George, P., Janus, E., & Weisgraber, K. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43175-x · Cited by 28
Steinmetz, A., Assefbarkhi, N., Eltze, C., Ehlenz, K., Funke, H., Pies, A., Assmann, G., & Kaffarnik, H. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42740-3 · Cited by 27
Self-citationClinical features of type III hyperlipoproteinemia: analysis of 64 patients
Feussner, G., Wagner, A., Kohl, B., & Ziegler, R. (1993) · The Clinical Investigator · doi:10.1007/bf00186624 · Cited by 27
Yamamura, T., Dong, L.-M., & Yamamoto, A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33364-2 · Cited by 25
Apolipoprotein E Mutants, Hyperlipidemia and Arteriosclerosis
Utermann, G. (1985) · Drugs Affecting Lipid Metabolism VIII · doi:10.1007/978-1-4613-2459-1_14 · Cited by 24
Self-citationDong, L.-M., Yamamura, T., & Yamamoto, A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92336-x · Cited by 23
Utermann, G. (1982) · La Ricerca in Clinica e in Laboratorio · doi:10.1007/bf02909306 · Cited by 23
Self-citationZannis, V. I., Ordovas, J. M., Cladaras, C., Cole, F. S., Forbes, G., & Schaefer, E. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38808-7 · Cited by 21
Idenitification and characterization of a new variant of apolipoprotein E (apo E-Kochi).
SUEHIRO, T., YOSHIDA, K., YAMANO, T., & OHNO, F. (1990) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.29.587 · Cited by 17
Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo ESuita)
Yanagi, K., Yamashita, S., Hiraoka, H., Ishigami, M., Kihara, S., Hirano, K.-I., Sakai, N., Nozaki, S., Funahashi, T., Kameda-Takemura, K., et al. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06068-6 · Cited by 16
Yamanouchi, Y., Arinami, T., Tsuchiya, S., Miyazaki, R., Takaki, H., Takano, T., & Hamaguchi, H. (1994) · Japanese journal of human genetics · doi:10.1007/bf01874050 · Cited by 15
Feussner, G., & Ziegler, R. (1992) · The Clinical Investigator · doi:10.1007/bf00184806 · Cited by 3
Metadata
- Authors
- Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M., & Canzler, H.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 1979-01
- Volume
- 15
- Issue
- 1
- Pages
- 37-62
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W1991306495
- Cited by
- 405
- References
- 36
- FWCI
- 16.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.